Table 1 UICC stages in correlation with CA19-9 serum levels (median and mean) and rate of elevated CA19-9 serum levels in patients with hilar cholangiocarcinoma.
From: Tumor markers as a diagnostic key for hilar cholangiocarcinoma
Variable | N = | N (elevated) = | Median CA19-9 levels(range) [U/ml] | Mean ± standard deviation CA19-9 levels [U/ml] |
|---|---|---|---|---|
UICC I | 26 | 15 (58%) | 70 (range: 0.8-2730) | 253 ± 561 |
UICC II | 64 | 51 (80%) | 146 (range:0.3-8566) | 742 ± 1572 |
UICC III | 17 | 16 (94%) | 255 (range:1-5879) | 906 ± 1708 |
UICC IV | 29 | 27 (93%) | 428 (range:16-13500) | 1707 ± 3053 |
Total | 136 | 109 (80%) | 173 (range:0.3-13500) | 874 ± 1910 |